BridgeMD
New treatment option for Stroke Rehabilitation
Official title Effects of Local Vibrations Program of Dorsiflexor Muscles on Neuromotor Recovery in Subacute Stroke Patients.
ClinicalTrials.gov ID: NCT05945212
What this study is testing
- What it's testing
- The aim of the vibration intervention proposed in the current study is to allow a better neuromotor recovery in subacute stroke patients when compared with standard rehabilitation alone. These last years, it has been proven that the solicitation of a muscle using vibrations may lead to positive effects on the neuromuscular function.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Stroke patients in subacute rehabilitation phase (between 14 days and 3 months post-stroke)
- Presenting with a stroke, ischemic or hemorrhagic
- Lower-limb deficiency with an initial motor testing \< 4 according to the MRC scale
- No neurological history with functional impact other than stroke
- Having received informed information about the study and having signed the written consent
You likely can't join if
- Multiple stroke
- Other neurological, cognitive or psychiatric conditions
- Orthopedic ankle history compromising measurements
- Botulinum toxin injected in the lower limb prior the study protocol
- Patient with phlebitis or risk of thrombosis in the lower limb
- Patient under tutorship
See the full eligibility criteria
- Stroke patients in subacute rehabilitation phase (between 14 days and 3 months post-stroke)
- Presenting with a stroke, ischemic or hemorrhagic
- Lower-limb deficiency with an initial motor testing \< 4 according to the MRC scale
- No neurological history with functional impact other than stroke
- Having received informed information about the study and having signed the written consent
- Affiliated or entitled to a social security scheme.
- Patients under guardianship may be included; they may give their consent with the assistance of their guardian. If the participant is unable to write, their consent may be given and documented by other appropriate means...
- Multiple stroke
- Other neurological, cognitive or psychiatric conditions
- Orthopedic ankle history compromising measurements
- Botulinum toxin injected in the lower limb prior the study protocol
- Patient with phlebitis or risk of thrombosis in the lower limb
- Patient under tutorship
The study team makes the final eligibility decision.
Where it's taking place
- Le Chambon-Feugerolles, France
- Rive-de-Gier, France
- Roanne, France
- Saint-Didier-au-Mont-d'Or, France
- Saint-Etienne, France
- Saint-Genis-Laval, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Le Chambon-Feugerolles, France; Rive-de-Gier, France; Roanne, France; Saint-Didier-au-Mont-d'Or, France; Saint-Etienne, France; Saint-Genis-Laval, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.